March 29, 2025Open Access

Prognostic value of neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma receiving curative therapies: a systematic review and meta-analysis

Key Points

Key points are not available for this paper at this time.

Abstract

Elevated NLR is significantly associated with poorer OS, RFS, and DFS in HCC patients receiving curative treatment. Future research should focus on validating the optimal NLR threshold and exploring its predictive ability in different clinical settings.

AIに質問

Bookmark

View Full Paper

Cite This Study

Peng et al. (Sat,) studied this question.

synapsesocial.com/papers/69d7224d8a0e2c5879bef5d6 https://doi.org/https://doi.org/10.1186/s12885-025-13972-w

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Innate immune cells and their interaction with T cells in hepatocellular carcinoma (Review)2020 · 18 citations
2Predictive indicators of immune therapy efficacy in hepatocellular carcinoma based on neutrophil-to-lymphocyte ratio2024 · 5 citations
3Prognostic Roles of Blood Inflammatory Markers in Hepatocellular Carcinoma Patients Taking Sorafenib. A Systematic Review and Meta-Analysis2020 · 30 citations
4The Prognostic Role of a Combined Fibrinogen and Neutrophil-to-Lymphocyte Ratio Score in Patients with Resectable Hepatocellular Carcinoma: A Retrospective Study2020 · 17 citations
5Association of metformin use and cancer incidence: a systematic review and meta-analysis2024 · 64 citations

AIに質問

Bookmark

View Full Paper